Tradestie Institutional Equity Comparison Engine

BMRA vs AYTU โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AYTU Overall Edge

AYTU Captures Institutional Edge (3โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to AYTU BioPharma, Inc. Common Stock (AYTU) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, BMRA trades at N/M Forward P/E with -125.2% operating margin (-8.3% YoY revenue) versus AYTU at 9.2x Forward P/E and -14.4% operating margin (+6.4% YoY). In options structure, BMRA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against AYTU sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner AYTU
BMRA N/M vs AYTU 9.2x Fwd P/E
Growth & Margin Winner AYTU
Op Margin -125.2% vs -14.4% ยท YoY -8.3% vs +6.4%
Momentum & Technical Winner AYTU
1Y -45.6% vs -12.1% ยท 52W Pos 5% vs 5%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
BMRA NASDAQ
Biomerica Inc
In Vitro & In Vivo Diagnostic Substances
$1.36
+0.0% 1D
Market Cap $6.0M
1M Return -26.49%
1Y Return -45.6%
Forward P/E N/M
Unified AI Score
44.5 / 100 HOLD
Tech 40.0 Fund 47.0 Flow 50.0 Mom 44.0
AYTU NASDAQ
AYTU BioPharma, Inc. Common Stock
Pharmaceutical Preparations
$1.81
+1.69% 1D
Market Cap $19.6M
1M Return -11.27%
1Y Return -12.14%
Forward P/E 9.2x
Unified AI Score
48.9 / 100 HOLD
Tech 49.0 Fund 53.0 Flow 50.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BMRA -45.6% AYTU -12.14% Spread: +33.46 pp (AYTU Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period BMRA Revenue AYTU Revenue BMRA Op. Margin AYTU Op. Margin Margin Edge
FY2019 $10M $10M -46.4% -230.1% BMRA
FY2020 $10M $30M -41.0% -76.5% BMRA
FY2021 $10M $70M -104.2% -89.7% AYTU
FY2022 $20M $100M -24.0% -113.7% BMRA
FY2023 $10M $110M -135.3% -15.9% AYTU
FY2024 $10M $70M -117.6% -2.4% AYTU
FY2025 $10M $70M -96.7% -11.8% AYTU
FY2026 $0M $60M -119.5% -14.4% AYTU

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BMRA (1) vs AYTU (9)
Institutional Metric BMRA AYTU Criterion Row Winner
Market Capitalization Scale $6.0M $19.6M Larger Scale AYTU
Trailing P/E Ratio Valuation N/M 9.2x Lower Multiple AYTU
Forward P/E Ratio Valuation N/M 9.2x Lower Multiple AYTU
Revenue Growth (YoY) Growth -8.3% +6.4% Higher Growth AYTU
Operating Margin (TTM) Profitability -125.2% -14.4% Higher Margin AYTU
Net Profit Margin Profitability -115.5% -24.8% Higher Margin AYTU
Return on Equity (ROE) Capital Efficiency -113.8% -52.5% Higher ROE AYTU
52-Week Range Position Momentum 5% ($1โ€“$3) 5% ($2โ€“$3) Stronger Trend BMRA
Beta / 30D Volatility Risk Regime 0.67ฮฒ ยท 62% Vol 0.65ฮฒ ยท 35% Vol Lower Realized Risk AYTU
Unified Institutional Score Composite Signal 44.5 / 100 (HOLD) 48.9 / 100 (HOLD) Higher Composite AYTU

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BMRA vs AYTU Buy Guide
BMRA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BMRA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
AYTU UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live AYTU Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BMRA nor AYTU registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.